Cargando…
Role of Glitazars in atherogenic dyslipidemia and diabetes: Two birds with one stone?
A triad of high triglycerides, low high-density lipoprotein (HDL) cholesterol, and elevated small dense low-density lipoprotein particles occurring in a patient with type 2 diabetes is referred to atherogenic diabetic dyslipidemia (ADD). Despite statin therapy, a significant residual risk remains po...
Autores principales: | Munigoti, Srinivasa P., Harinarayan, C. V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056123/ https://www.ncbi.nlm.nih.gov/pubmed/24944919 http://dx.doi.org/10.4103/2230-8210.131134 |
Ejemplares similares
-
Atherogenic dyslipidemia
por: Manjunath, C. N., et al.
Publicado: (2013) -
Terpene-Containing Analogues of Glitazars as Potential Therapeutic Agents for Metabolic Syndrome
por: Blokhin, Mikhail E., et al.
Publicado: (2023) -
Atherogenic dyslipidemia and diabetes mellitus: what’s new in the management arena?
por: Kumar, Ajoy, et al.
Publicado: (2010) -
Baricitinib: Two Birds with One Stone
por: Saj, Fen, et al.
Publicado: (2022) -
Atherogenic Dyslipidemia: Cardiovascular Risk and Dietary Intervention
por: Musunuru, Kiran
Publicado: (2010)